Catalyst Wire Dossier Catalyst Wire Dossier

Haploidentical CD34+ selected cells combined with single-unit umbilical cord blood transplant

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Haploidentical CD34+ selected cells combined with single-unit umbilical cord blood transplant, covering 2025-08-15 to 2025-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic Disorders [NA]

See pricing